Mona Jacobson
A5077266739- COVID-19 and healthcare impacts
- Telemedicine and Telehealth Implementation
- Genetics and Neurodevelopmental Disorders
- Epilepsy research and treatment
- Emergency and Acute Care Studies
- Genomics and Rare Diseases
- Healthcare Systems and Technology
Children's Hospital Colorado
2020-2022
University of Colorado Denver
2020-2022
Colorado School of Public Health
2020
It is currently unknown how often and in which ways a genetic diagnosis given to patient with epilepsy associated clinical management outcomes. To evaluate diagnoses patients are This was retrospective cross-sectional study of referred for multigene panel testing between March 18, 2016, August 3, 2020, outcomes reported May November 2020. The setting included commercial laboratory multicenter practices. Patients epilepsy, regardless sociodemographic features, who received pathogenic/likely...
To examine whether telemedicine remains safe and of high quality despite rapid expansion services by comparing encounters before during the COVID-19 pandemic.Pre-post study investigating 2,999 encounters: February 1, 2020-May 15, 2020, was performed. A total 2,919 completed visits after strict social distancing implementation were analyzed for patient provider characteristics, encounter characteristics (e.g., history physical examination), safety metrics (phone calls ≤ 7 days postvisit,...
We compared emergency department (ED) and overnight inpatient admission (admission) rates within eight weeks of home-based telemedicine visits during COVID-19 in 2020 with in-person (conventional visit) 2019. This was a quality improvement project prompted by an adverse event after visit.We reviewed all completed conventional from March 26 to June 1 2019 identify patients who required ED visit or hospital the visit.In 2020, overall rate neurology less than 5%. Comparing 2019: (1) cohorts...